Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 474.35 million compared to CNY 501.41 million a year ago. Revenue was CNY 474.35 million compared to CNY 501.41 million a year ago.

Net income was CNY 93.93 million compared to CNY 92.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.6487 compared to CNY 0.6404 a year ago. Diluted earnings per share from continuing operations was CNY 0.6487 compared to CNY 0.6404 a year ago.